Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 31, 2021
Hepatitis E Virus Species C Infection in Humans, Hong Kong
Siddharth Sridhar, Cyril Chik Yan Yip, Kelvin Hon Yin Lo, et al.
AIDS Research and Human Retroviruses
|
September 9, 2021
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
Ross D Cranston, Elizabeth Brown, José Bauermeister, et al.
The Journal of Infectious Diseases
|
November 29, 2023
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)
Ethel D Weld, Ian McGowan, Peter Anton, et al.
Sexually Transmitted Infections
|
July 25, 2025
Prevalence of chlamydial, gonococcal and syphilis positivity by anatomical site and sex via self-collected biospecimens using at-home testing kits among a large and diverse cohort of men and women enrolled in the MACS/WIHS Combined Cohort Study (MWCCS) in the USA
Matthew J Mimiaga, Jiahao Tian, Izzy Chiu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2025
Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037)
Ken Ho, Craig Hoesley, Peter L Anderson, et al.
AIDS and Behavior
|
June 10, 2022
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)
Kenneth H Mayer, Krista Yuhas, K Rivet Amico, et al.
Endocrine Connections
|
February 28, 2018
Growth Hormone Research Society perspective on biomarkers of GH action in children and adults
Gudmundur Johannsson, Martin Bidlingmaier, Beverly M K Biller, et al.
The Journal of Infectious Diseases
|
November 5, 2016
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)
Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
Emerging Infectious Diseases
|
January 25, 2024
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021
Jessica Justman, Timothy Skalland, Ayana Moore, et al.
Annals of Internal Medicine
|
August 23, 2017
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial
Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 31, 2021
Hepatitis E Virus Species C Infection in Humans, Hong Kong
Siddharth Sridhar, Cyril Chik Yan Yip, Kelvin Hon Yin Lo, et al.
AIDS Research and Human Retroviruses
|
September 9, 2021
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
Ross D Cranston, Elizabeth Brown, José Bauermeister, et al.
The Journal of Infectious Diseases
|
November 29, 2023
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)
Ethel D Weld, Ian McGowan, Peter Anton, et al.
Sexually Transmitted Infections
|
July 25, 2025
Prevalence of chlamydial, gonococcal and syphilis positivity by anatomical site and sex via self-collected biospecimens using at-home testing kits among a large and diverse cohort of men and women enrolled in the MACS/WIHS Combined Cohort Study (MWCCS) in the USA
Matthew J Mimiaga, Jiahao Tian, Izzy Chiu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2025
Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037)
Ken Ho, Craig Hoesley, Peter L Anderson, et al.
AIDS and Behavior
|
June 10, 2022
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)
Kenneth H Mayer, Krista Yuhas, K Rivet Amico, et al.
Endocrine Connections
|
February 28, 2018
Growth Hormone Research Society perspective on biomarkers of GH action in children and adults
Gudmundur Johannsson, Martin Bidlingmaier, Beverly M K Biller, et al.
The Journal of Infectious Diseases
|
November 5, 2016
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)
Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
Emerging Infectious Diseases
|
January 25, 2024
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021
Jessica Justman, Timothy Skalland, Ayana Moore, et al.
Annals of Internal Medicine
|
August 23, 2017
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial
Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
Page
of 9